CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, will release its third quarter financial results on Thursday, November 9, 2006 before the market opens. The Company will also hold a conference call to discuss the financial results, progress of its therapeutic product development programs, and additional corporate activities at 10:00 A.M. Eastern time. Daniel Passeri, President and Chief Executive Officer of Curis, will host the call.
